Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Live Vaccines against Serologic Subtypes of Infectious Bursal Disease Virus

1 Jan 1990

Abstract excerpt

Experiments determined the efficacy of live vaccines in specific-pathogen-free broilers against serologic subtypes of infectious bursal disease virus (IBDV). Challenge isolates were the Delmarva variant E, a standard serotype I (APHIS) and a variant isolate from Mississippi. The vaccines were a cloned standard (CS) vaccine (Clone Vac-D78), a cloned variant (CV) vaccine (Bursa Vac IV), and an uncloned standard...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Parasitic Diseases Research and Treatment
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 2157398
DOI: 10.2307/1591328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Live Vaccines against Serologic Subtypes of Infectious Bursal Disease VirusPMID 2157398Read ↗

Immunogenicity of Infectious Bursal Disease Viruses in ChickensSemantic proximity Read ↗

Massachusetts live vaccination protects against a novel infectious bronchitis virus S1 genotype DMV/5642/06.Semantic proximity Read ↗

Molecular and phenotypic characterization of infectious bursal disease virus isolates.Semantic proximity Read ↗

Comparison of Viral Shedding Following Vaccination With Inactivated and Live Newcastle Disease Vaccines Formulated With Wild-Type and Recombinant VirusesSemantic proximity Read ↗

Antigenic and molecular characterization of three infectious bursal disease virus field isolates.Semantic proximity Read ↗

Sequence Analysis and Expression of the Host-protective Immunogen VP2 of a Variant Strain of Infectious Bursal Disease Virus Which Can Circumvent Vaccination with Standard Type I StrainsSemantic proximity Read ↗

Sequence comparisons of the variable VP2 region of eight infectious bursal disease virus isolates.Semantic proximity Read ↗

Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge virusesSemantic proximity Read ↗

In vivo challenge studies on vaccinated chickens indicate a virus genotype mismatched vaccine still offers significant protection against NDV.Semantic proximity Read ↗

Use of a Vectored Vaccine against Infectious Bursal Disease of Chickens in the Face of High-Titred Maternally Derived AntibodySemantic proximity Read ↗

Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys.Semantic proximity Read ↗

Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.